WO2002024215A3 - Method for using activated protein c for the treatment of coagulation-associated disorders - Google Patents
Method for using activated protein c for the treatment of coagulation-associated disorders Download PDFInfo
- Publication number
- WO2002024215A3 WO2002024215A3 PCT/US2001/026028 US0126028W WO0224215A3 WO 2002024215 A3 WO2002024215 A3 WO 2002024215A3 US 0126028 W US0126028 W US 0126028W WO 0224215 A3 WO0224215 A3 WO 0224215A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- activated protein
- coagulation
- treatment
- associated disorders
- remains
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001290553A AU2001290553A1 (en) | 2000-09-18 | 2001-09-17 | Method for using activated protein c for the treatment of coagulation-associated disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23363600P | 2000-09-18 | 2000-09-18 | |
US60/233,636 | 2000-09-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002024215A2 WO2002024215A2 (en) | 2002-03-28 |
WO2002024215A3 true WO2002024215A3 (en) | 2003-05-22 |
Family
ID=22878074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/026028 WO2002024215A2 (en) | 2000-09-18 | 2001-09-17 | Method for using activated protein c for the treatment of coagulation-associated disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001290553A1 (en) |
WO (1) | WO2002024215A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008199A (en) * | 1997-10-20 | 1999-12-28 | Eli Lilly And Company | Methods for treating hypercoagulable states or acquired protein C deficiency |
WO2000030677A1 (en) * | 1998-11-20 | 2000-06-02 | Eli Lilly And Company | Method of treating viral hemorrhagic fever |
WO2000030676A1 (en) * | 1998-11-23 | 2000-06-02 | Eli Lilly And Company | Method of treating sickle cell disease and thalassemia |
WO2001089558A2 (en) * | 2000-05-24 | 2001-11-29 | Eli Lilly And Company | Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
-
2001
- 2001-09-17 AU AU2001290553A patent/AU2001290553A1/en not_active Abandoned
- 2001-09-17 WO PCT/US2001/026028 patent/WO2002024215A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008199A (en) * | 1997-10-20 | 1999-12-28 | Eli Lilly And Company | Methods for treating hypercoagulable states or acquired protein C deficiency |
WO2000030677A1 (en) * | 1998-11-20 | 2000-06-02 | Eli Lilly And Company | Method of treating viral hemorrhagic fever |
WO2000030676A1 (en) * | 1998-11-23 | 2000-06-02 | Eli Lilly And Company | Method of treating sickle cell disease and thalassemia |
WO2001089558A2 (en) * | 2000-05-24 | 2001-11-29 | Eli Lilly And Company | Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
Also Published As
Publication number | Publication date |
---|---|
AU2001290553A1 (en) | 2002-04-02 |
WO2002024215A2 (en) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003264354A1 (en) | Medical treatment system, endoscope system, endoscope insert operation program, and endoscope device | |
AU2002255248A1 (en) | Diagnosis, treatment and research of mental disorders | |
DE69535349D1 (en) | An implantable active medical device having means for discriminating between resting and active states of the patient | |
AU2003231011A1 (en) | Independent therapy programs in an implantable medical device | |
AU2001275177A1 (en) | Cardiac disease treatment and device | |
AU2001275176A1 (en) | Cardiac disease treatment and device | |
AU2001253565A1 (en) | Cardiac disease treatment and device | |
AU2001281369A1 (en) | Cardiac disease treatment and device | |
WO2005000161A3 (en) | Methods and devices for occluding body lumens and/or for delivering therapeutic agents | |
AU2003303382A1 (en) | System providing emergency medical care with real-time instructions and associated methods | |
EP2289443A3 (en) | Faceted ultrasound medical transducer assembly | |
AU2001276991A1 (en) | Patient-controlled automated medical record, diagnosis, and treatment system andmethod | |
DE60116784D1 (en) | PATIENT-CONTROLLED THERAPY MANAGEMENT | |
AU2002368364A1 (en) | Instrument for cryogenic treatments in the medical, paramedical and cosmetic field | |
AU2003272951A1 (en) | Balloon catheter and device for injecting medical treatment method | |
WO2003062273A3 (en) | Modulator of the notch signalling pathway and use thereof in medical treatment | |
AU2002252225A1 (en) | Physiological monitor for veterinary and human medical use and method | |
AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
DK1265577T3 (en) | Medical or dental medical treatment chair | |
DE60216970D1 (en) | IMPLANTABLE HEART STIMULATING DEVICE AND SYSTEM COMPRISING THIS DEVICE | |
GB9704352D0 (en) | Levobupivacaine and its use | |
AU6539000A (en) | Composition and method for treating disease by increasing activated alpha2 macroglobulin in the blood and extravascular tissue | |
WO2001089558A3 (en) | Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states | |
AU2001233955A1 (en) | Diagnosis and treatment of bipolar affective disorder | |
WO2002024215A3 (en) | Method for using activated protein c for the treatment of coagulation-associated disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref country code: RU Ref document number: 2002 2002123299 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: RU Ref document number: 2002 2002123661 Kind code of ref document: A Format of ref document f/p: F |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WA | Withdrawal of international application | ||
122 | Ep: pct application non-entry in european phase |